Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04337931
Title A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Apexigen, Inc.
Indications

melanoma

Therapies

APX005M

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Maria Sklodowska-Curie National Research Institute of Oncology Recruiting Warsaw Poland Details
H. Quirón Dexeus Recruiting Barcelona Spain Details
H. Vall d'Hebron Recruiting Barcelona Spain Details
H. Insular de Gran Canaria Recruiting Las Palmas De Gran Canaria Spain Details
H. Virgen de la Arrixaca Recruiting Murcia Spain Details
H. R. U. de Málaga Recruiting Málaga Spain Details
Clinica Universitaria de Navarra Recruiting Pamplona Spain Details
Hospital Universitario Marqués De Valdecilla Recruiting Santander Spain Details
H. U. de Canarias Recruiting Tenerife Spain Details
Fundación Instituto Valenciano De Oncología Recruiting Valencia Spain Details
H. U. Dr. Peset Recruiting Valencia Spain Details
C. H. U.de Vigo Recruiting Vigo Spain Details
H. U. Miguel Servet Recruiting Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field